Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) FCF Margin (2016 - 2025)

Myriad Genetics (MYGN) has disclosed FCF Margin for 17 consecutive years, with 2.81% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 139.0% to 2.81% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.67% through Dec 2025, up 163.0% year-over-year, with the annual reading at 1.67% for FY2025, 163.0% up from the prior year.
  • FCF Margin for Q4 2025 was 2.81% at Myriad Genetics, down from 8.9% in the prior quarter.
  • The five-year high for FCF Margin was 37.38% in Q1 2021, with the low at 39.24% in Q3 2023.
  • Average FCF Margin over 5 years is 8.1%, with a median of 4.4% recorded in 2021.
  • The sharpest move saw FCF Margin crashed -6940bps in 2022, then skyrocketed 3793bps in 2024.
  • Over 5 years, FCF Margin stood at 3.17% in 2021, then crashed by -229bps to 4.11% in 2022, then plummeted by -702bps to 32.91% in 2023, then surged by 104bps to 1.42% in 2024, then soared by 97bps to 2.81% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 2.81%, 8.9%, and 7.7% for Q4 2025, Q3 2025, and Q2 2025 respectively.